Lipoprotein X in the Setting of COVID-19–Induced Cholangiopathy: An Unforeseen Event
Elevated low-density lipoprotein cholesterol (LDL-C) is a well-known culprit for atherosclerosis; however, elevated lipoprotein X (LpX), an abnormal lipoprotein as dense as LDL-C, may confound differentiation between true hyperlipidemia and cholestasis-induced hyperlipidemia. We present the case of...
Saved in:
| Main Authors: | Hardik Patel, Felix Berglund, Christina C. Lindenmeyer, Nicholas Ruthmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-01-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2023.0813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Induced Cholangiopathy: A Case Report
by: Bassem Al Hariri, et al.
Published: (2025-07-01) -
A Case Series of Recreational Ketamine-Induced Cholangiopathy
by: Larisa K. Garkusha, et al.
Published: (2024-07-01) -
Cholangiopathy: Genetics, Mechanism, and Pathology
by: Yasuni Nakanuma, et al.
Published: (2012-01-01) -
Cholangiopathy with Respect to Biliary Innate Immunity
by: Kenichi Harada, et al.
Published: (2012-01-01) -
Unveiling the Unforeseen
by: Steve Henry, et al.
Published: (2024-10-01)